
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health Inc. demonstrated significant growth in its Integrated Care segment, with membership rising to 102.5 million, an increase from 91.8 million a year prior and above the previous quarter's 93.8 million. The company reported an operating cash flow increase to $15.9 million year-over-year and finished the first quarter with cash and cash equivalents totaling $1,193.3 million, indicating solid financial health and liquidity. Although revenue growth for the upcoming quarter is modestly estimated at 3.5%, the stable customer acquisition cost trends and increasing membership point towards a positive outlook for the company's long-term performance.
Bears say
Teladoc Health Inc. has experienced a decline in its BetterHelp user base, falling to 397,000, which is down from both the previous quarter and the same quarter last year, indicating a concerning trend in user engagement. The company's reaffirmed FY25 topline guidance, while overshadowed by the anticipated negative impact of the Uplift initiative, has resulted in a reduction of EBITDA forecasts, reflecting potential challenges in achieving profitability. Additionally, the total revenue saw a year-over-year decline of 2.6%, largely driven by a 10.8% contraction in BetterHelp revenue, despite moderate growth in the Integrated Care segment, highlighting underlying issues within its core offerings.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares